These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 17915563)

  • 1. The emerging diversity of neuromuscular junction disorders.
    Newsom-Davis J
    Acta Myol; 2007 Jul; 26(1):5-10. PubMed ID: 17915563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical neurophysiology of disorders of the neuromuscular junction.
    Sanders DB
    J Clin Neurophysiol; 1993 Apr; 10(2):167-80. PubMed ID: 8389381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disorders of neuromuscular junction ion channels.
    Boonyapisit K; Kaminski HJ; Ruff RL
    Am J Med; 1999 Jan; 106(1):97-113. PubMed ID: 10320124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurophysiological testing in myasthenia syndromes].
    Kostera-Pruszczyk A; Rowińska-Marcińska K; Emeryk-Szajewska B
    Neurol Neurochir Pol; 2003; 37(1):161-72. PubMed ID: 12910838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Editorial introduction: from the structure and functions of the neuromuscular junction to the diseases].
    Takamori M
    Brain Nerve; 2011 Jul; 63(7):635-40. PubMed ID: 21747132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the response to low-frequency repetitive nerve stimulation of myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Miralles F
    Med Biol Eng Comput; 2016 Nov; 54(11):1761-1778. PubMed ID: 27016366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of myasthenia explained.
    Verschuuren JJ; Palace J; Gilhus NE
    Autoimmunity; 2010 Aug; 43(5-6):344-52. PubMed ID: 20380587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of myasthenia gravis and Lambert-Eaton syndrome.
    Maselli RA
    Neurol Clin; 1994 May; 12(2):285-303. PubMed ID: 8041343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to ion channels at the neuromuscular junction.
    Lang B; Vincent A
    Autoimmun Rev; 2003 Mar; 2(2):94-100. PubMed ID: 12848965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiology on the disorder of neuromuscular transmission defects].
    Sahashi K; Ibi T
    Rinsho Byori; 1995 Sep; 43(9):902-9. PubMed ID: 7474453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of firing rate on neuromuscular jitter in Lambert-Eaton myasthenic syndrome.
    Sanders DB
    Muscle Nerve; 1992 Feb; 15(2):256-8. PubMed ID: 1549148
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoimmune disorders of the neuromuscular junction.
    Vincent A
    Neurol India; 2008; 56(3):305-13. PubMed ID: 18974557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.
    Vincent A; Beeson D; Lang B
    Eur J Biochem; 2000 Dec; 267(23):6717-28. PubMed ID: 11082182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pathophysiology and treatment of autoimmune neuromuscular junction diseases].
    Motomura M
    Rinsho Shinkeigaku; 2011 Nov; 51(11):872-6. PubMed ID: 22277398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular junction disorders.
    Verschuuren J; Strijbos E; Vincent A
    Handb Clin Neurol; 2016; 133():447-66. PubMed ID: 27112691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders.
    Ohno K; Ohkawara B; Ito M
    Expert Opin Ther Targets; 2017 Oct; 21(10):949-958. PubMed ID: 28825343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune mediated neuromuscular junction defects.
    Farrugia ME; Vincent A
    Curr Opin Neurol; 2010 Oct; 23(5):489-95. PubMed ID: 20651592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurophysiological aspects of diagnosis in neuromuscular transmission defects--an update.
    Stålberg E
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():377-85. PubMed ID: 10689484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.